NUPR2 is a nuclear transcriptional regulator that functions as a negative regulator of the protumoral protein NUPR1. As a p53-dependent transcriptional repressor, NUPR2 inhibits gene expression at the NUPR1 promoter in cancer cells, thereby suppressing cell proliferation and promoting G1 cell cycle arrest 1. NUPR2 belongs to a conserved family of small chr7-binding proteins structurally related to helix-loop-helix HMG proteins, yet distinct in their posttranslational modification sites and DNA-binding properties 2. Mechanistically, NUPR2 operates as an intrinsically disordered protein capable of binding nuclear import machinery and interacting with other chr7 regulators 3. Beyond cancer biology, NUPR2 appears relevant to neurodegenerative disease; it was the only gene in the DNA damage response pathway differentially expressed between sporadic and C9orf72-repeat-expansion frontotemporal dementia patient-derived neurons, suggesting a potential role in neurodegeneration-associated DNA repair mechanisms 4. Through its dual capacity to suppress NUPR1 expression and regulate cell cycle progression, NUPR2 may function as a stress-response tumor suppressor, though its clinical significance and therapeutic potential remain incompletely characterized compared to its well-studied paralogue NUPR1.